• Latest Posts

ADC Approval Buoys Spirits in Cancer Treatment Space

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

MSD Offers €464M to Buy German Biotech Fighting Cancer with RNA

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Berlin Biotech Advances its Cancer Drug in a New Trial with Keytruda

ADVERTISEMENT

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

UPDATE: Sanofi defeated in the Race to acquire Medivation

And now, Immuno-oncology gets EMA’s pre-approval for Lung Cancer

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

New Discovery unites Australia, Germany and UK Against Blood Cancers

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial

ADVERTISEMENT